We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+15.53%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$38.7B
AUM Growth
+$5.1B
(+15%)
Cap. Flow
+$551M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
24.47%
Holding
1,486
New
101
Increased
869
Reduced
411
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$130M |
| 2 |
Franco-Nevada
FNV
|
+$128M |
| 3 |
B
Barrick Mining
B
|
+$98.9M |
| 4 |
Dominion Energy
D
|
+$96M |
| 5 |
Monolithic Power Systems
MPWR
|
+$88.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$133M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$104M |
| 3 |
SLB Ltd
SLB
|
+$90.4M |
| 4 |
Blackrock
BLK
|
+$89.1M |
| 5 |
Honeywell
HON
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 35.79% |
| 2 | Technology | 25.85% |
| 3 | Energy | 9% |
| 4 | Healthcare | 6.56% |
| 5 | Financials | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
United Therapeutics
UTHR
$22B
| $428K | ﹤0.01% |
1,540
+208
| +16% | +$52.5K |
|
952
Uber
UBER
$147B
| $425K | ﹤0.01% |
17,173
+2,200
| +15% | +$60.2K |
|
953
ICU Medical
ICUI
$4.3B
| $423K | ﹤0.01% |
2,683
+2,124
| +380% | +$323K |
|
954
Builders FirstSource
BLDR
$8.11B
| $419K | ﹤0.01% |
6,457
-101
| -2% | -$6.31K |
|
955
Eastman Chemical
EMN
$8.45B
| $419K | ﹤0.01% |
+5,140
| New | +$414K |
|
956
Fortive
FTV
$18.3B
| $419K | ﹤0.01% |
+8,649
| New | +$419K |
|
957
Norwegian Cruise Line
NCLH
$9.22B
| $418K | ﹤0.01% |
+102,762
| New | +$1.55M |
|
|
WCC
958
WESCO International
WCC
$18.2B
| $417K | ﹤0.01% |
+3,332
| New | +$419K |
|
959
F5
FFIV
$23.4B
| $406K | ﹤0.01% |
2,832
-4,252
| -60% | -$622K |
|
960
American Airlines Group
AAL
$11B
| $402K | ﹤0.01% |
31,593
-584
| -2% | -$7.92K |
|
|
DFS
961
DELISTED
Discover Financial Services
DFS
| $402K | ﹤0.01% |
+4,107
| New | +$413K |
|
962
SiriusXM
SIRI
$10.4B
| $402K | ﹤0.01% |
+6,878
| New | +$423K |
|
963
Lindsay Corp
LNN
$1.2B
| $401K | ﹤0.01% |
2,462
+235
| +11% | +$38.8K |
|
964
FuelCell Energy
FCEL
$1.8B
| $399K | ﹤0.01% |
4,787
+274
| +6% | +$26.4K |
|
|
AZUL
965
DELISTED
Azul
AZUL
| $398K | ﹤0.01% |
65,123
+5,961
| +10% | +$46.5K |
|
966
Cousins Properties
CUZ
$5.09B
| $398K | ﹤0.01% |
15,754
+6,997
| +80% | +$171K |
|
967
CVR Energy
CVI
$3.35B
| $398K | ﹤0.01% |
12,709
+83
| +0.7% | +$2.95K |
|
968
Western Digital
WDC
$189B
| $398K | ﹤0.01% |
16,678
-600
| -3% | -$15.8K |
|
969
LKQ Corp
LKQ
$6.2B
| $397K | ﹤0.01% |
7,434
+437
| +6% | +$23.1K |
|
970
Deckers Outdoor
DECK
$13.6B
| $396K | ﹤0.01% |
5,952
+858
| +17% | +$51.9K |
|
971
Advance Auto Parts
AAP
$3.55B
| $395K | ﹤0.01% |
+2,685
| New | +$435K |
|
972
Northwest Natural Holdings
NWN
$2.05B
| $395K | ﹤0.01% |
8,291
+1,294
| +18% | +$60.7K |
|
973
Ares Management
ARES
$32.2B
| $392K | ﹤0.01% |
5,732
+35
| +0.6% | +$2.52K |
|
974
Hudbay
HBM
$11B
| $390K | ﹤0.01% |
77,234
-593
| -0.8% | -$2.86K |
|
975
Roku
ROKU
$21.9B
| $388K | ﹤0.01% |
9,545
-1,194
| -11% | -$62.4K |
|
Similar funds
VanEck Associates's Q4 2022 Portfolio in Review
As of Q4 2022, VanEck Associates held 1,486 positions worth $38.7B, up 15% from $33.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
VanEck Associates's Q4 2022 filing shows 101 new, 869 increased, 411 reduced and 62 closed positions. Its largest new stake was NextEra Energy, Inc. 6.926% Corporate Units: 631,037 shares worth $31.7M. The largest sale was Gilead Sciences, an estimated $133M.
By sector, the portfolio is most concentrated in Materials at 36% of assets, up from 34% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q4 2022 buy was NextEra Energy, Inc. 6.926% Corporate Units: 631,037 shares worth $31.7M.
- VanEck Associates added most to Newmont in Q4 2022, an estimated $130M increase.
- VanEck Associates's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $133M.
- VanEck Associates fully exited Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q4 2022, selling an estimated $29.4M.
- VanEck Associates's ten largest holdings make up 24% of its $38.7B portfolio in Q4 2022.
- VanEck Associates opened 101 new positions and closed 62 in Q4 2022.
- VanEck Associates's portfolio value rose 15% quarter-over-quarter to $38.7B.
Based on VanEck Associates's 13F filing for Q4 2022, filed 8 Feb 2023.